Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1984 Sep;45(3):718–725. doi: 10.1128/iai.45.3.718-725.1984

In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.

B D Meade, P D Kind, J B Ewell, P P McGrath, C R Manclark
PMCID: PMC263356  PMID: 6088394

Abstract

Lymphocytosis promoting factor (LPF) of Bordetella pertussis is a protein toxin which may have a role in the pathogenesis of pertussis. Since macrophages have an important role in the control of respiratory infections, the in vitro effects of LPF on macrophages from C3H/HeN and C3H/HeJ mice and on a murine macrophage-like cell line, RAW264, were examined. LPF inhibited random migration of resident peritoneal macrophages as well as the chemotaxis of peritoneal macrophages and the cell line. Fifty percent inhibition of chemotaxis occurred at 0.2 to 0.3 ng of LPF per ml for the macrophages and at 1 to 2 ng of LPF per ml for the cell line. When LPF was either heated at 80 degrees C for 5 min or premixed with specific antibodies, it failed to inhibit migration. At 20 ng/ml, LPF inhibited chemotaxis by more than 80% and also decreased Fc-mediated phagocytosis by 25 to 35%. At this dose, LPF was not a chemoattractant for murine macrophages and did not reduce macrophage viability, adherence, or opsonized zymosan-stimulated superoxide release. When LPF-treated macrophages were added to tissue culture dishes and then examined microscopically after 4 h, the LPF-treated cells adhered but failed to spread and elongate as well as control macrophages. These data indicate that LPF specifically inhibits macrophage migration in vitro and suggest that a possible role for LPF in pathogenesis is to inhibit migration of macrophages to the site of B. pertussis infection.

Full text

PDF
718

Images in this article

723Image
on p.723

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aksamit R. R., Falk W., Leonard E. J. Chemotaxis by mouse macrophage cell lines. J Immunol. 1981 Jun;126(6):2194–2199. [PubMed] [Google Scholar]
  2. Asakawa S., Iwasa S. The effect of Bordetella pertussis lymphocytosis-promoting factor (LPF) on antibody response in mice: its enhancing and suppressive effects. Jpn J Med Sci Biol. 1982 Feb;35(1):25–29. doi: 10.7883/yoken1952.35.25. [DOI] [PubMed] [Google Scholar]
  3. Badr-El-Din M. K., Aref G. H., Mazloum H., El-Towesy Y. A., Kassem A. S., Abdel-Moneim M. A., Abbassy A. A. The beta-adrenergic receptors in pertussis. J Trop Med Hyg. 1976 Oct;79(10):213–217. [PubMed] [Google Scholar]
  4. Benjamin W. R., Klein T. W., Pross S. H., Friedman H. Inhibition of mononuclear phagocyte elongation, migration, and cellular exudate formation following Bordetella pertussis vaccine administration. Proc Soc Exp Biol Med. 1981 Feb;166(2):249–256. doi: 10.3181/00379727-166-41054. [DOI] [PubMed] [Google Scholar]
  5. Bokoch G. M., Katada T., Northup J. K., Hewlett E. L., Gilman A. G. Identification of the predominant substrate for ADP-ribosylation by islet activating protein. J Biol Chem. 1983 Feb 25;258(4):2072–2075. [PubMed] [Google Scholar]
  6. Cantarow W. D., Cheung H. T., Sundharadas G. Effects of prostaglandins on the spreading, adhesion and migration of mouse peritoneal macrophages. Prostaglandins. 1978 Jul;16(1):39–46. doi: 10.1016/0090-6980(78)90200-9. [DOI] [PubMed] [Google Scholar]
  7. Cianciolo G. J., Snyderman R. Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants. J Clin Invest. 1981 Jan;67(1):60–68. doi: 10.1172/JCI110033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Confer D. L., Eaton J. W. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science. 1982 Sep 3;217(4563):948–950. doi: 10.1126/science.6287574. [DOI] [PubMed] [Google Scholar]
  9. De Harven E., Beju D., Evenson D. P., Basu S., Schidlovsky G. Structure of critical point dried oncornaviruses. Virology. 1973 Oct;55(2):535–540. doi: 10.1016/0042-6822(73)90198-0. [DOI] [PubMed] [Google Scholar]
  10. Densen P., Mandell G. L. Phagocyte strategy vs. microbial tactics. Rev Infect Dis. 1980 Sep-Oct;2(5):817–838. doi: 10.1093/clinids/2.5.817. [DOI] [PubMed] [Google Scholar]
  11. Falk W., Goodwin R. H., Jr, Leonard E. J. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods. 1980;33(3):239–247. doi: 10.1016/0022-1759(80)90211-2. [DOI] [PubMed] [Google Scholar]
  12. Falk W., Leonard E. J. Chemotaxis of purified human monocytes in vitro: lack of accessory cell requirement. Infect Immun. 1982 May;36(2):591–597. doi: 10.1128/iai.36.2.591-597.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gallin J. I., Sandler J. A., Clyman R. I., Manganiello V. C., Vaughan M. Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion. J Immunol. 1978 Feb;120(2):492–496. [PubMed] [Google Scholar]
  14. Geller B. D., Pittman M. immunoglobulin and histamine-sensitivity response of mice to live Bordetella pertussis. Infect Immun. 1973 Jul;8(1):83–90. doi: 10.1128/iai.8.1.83-90.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Green G. M., Jakab G. J., Low R. B., Davis G. S. Defense mechanisms of the respiratory membrane. Am Rev Respir Dis. 1977 Mar;115(3):479–514. doi: 10.1164/arrd.1977.115.3.479. [DOI] [PubMed] [Google Scholar]
  16. Hildebrandt J. D., Sekura R. D., Codina J., Iyengar R., Manclark C. R., Birnbaumer L. Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature. 1983 Apr 21;302(5910):706–709. doi: 10.1038/302706a0. [DOI] [PubMed] [Google Scholar]
  17. Hochstein H. D. Review of the Bureau of Biologic's experience with Limulus amebocyte lysate and endotoxin. Prog Clin Biol Res. 1982;93:141–151. [PubMed] [Google Scholar]
  18. Imagawa T., Kanoh M., Sonoda S., Utsumi S. Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. III. Inhibition of Arthus reaction and peritoneal infiltration of PMN. Microbiol Immunol. 1980;24(10):895–905. doi: 10.1111/j.1348-0421.1980.tb02895.x. [DOI] [PubMed] [Google Scholar]
  19. Katada T., Ui M. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc Natl Acad Sci U S A. 1982 May;79(10):3129–3133. doi: 10.1073/pnas.79.10.3129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Katada T., Ui M. Slow interaction of islet-activating protein with pancreatic islets during primary culture to cause reversal of alpha-adrenergic inhibition of insulin secretion. J Biol Chem. 1980 Oct 25;255(20):9580–9588. [PubMed] [Google Scholar]
  21. Kuehn C., Van Epps D. E. Lectin-mediated induction of human neutrophil chemotaxis, chemokinesis, and cap formation. Infect Immun. 1980 Aug;29(2):600–608. doi: 10.1128/iai.29.2.600-608.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lehrer S. B., Tan E. M., Vaughan J. H. Extraction and partial purification of the histamine-sensitizing factor of Bordetella pertussis. J Immunol. 1974 Jul;113(1):18–26. [PubMed] [Google Scholar]
  23. Leonard E. J., Skeel A. Effects of cell concentration on chemotactic responsiveness of mouse resident peritoneal macrophages. J Reticuloendothel Soc. 1981 Oct;30(4):271–282. [PubMed] [Google Scholar]
  24. Levine S., Sowinski R. Inhibition of macrophage response to brain injury. A new effect of pertussis vaccine possibly related to histamine-sensitizing factor. Am J Pathol. 1972 May;67(2):349–360. [PMC free article] [PubMed] [Google Scholar]
  25. Morse J. H., Kong A. S., Lindenbaum J., Morse S. I. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes. J Clin Invest. 1977 Sep;60(3):683–692. doi: 10.1172/JCI108820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Morse S. I., Morse J. H. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J Exp Med. 1976 Jun 1;143(6):1483–1502. doi: 10.1084/jem.143.6.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Munoz J. J., Arai H., Bergman R. K., Sadowski P. L. Biological activities of crystalline pertussigen from Bordetella pertussis. Infect Immun. 1981 Sep;33(3):820–826. doi: 10.1128/iai.33.3.820-826.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Murayama T., Ui M. Loss of the inhibitory function of the guanine nucleotide regulatory component of adenylate cyclase due to its ADP ribosylation by islet-activating protein, pertussis toxin, in adipocyte membranes. J Biol Chem. 1983 Mar 10;258(5):3319–3326. [PubMed] [Google Scholar]
  29. Nathan C. F., Murray H. W., Cohn Z. A. The macrophage as an effector cell. N Engl J Med. 1980 Sep 11;303(11):622–626. doi: 10.1056/NEJM198009113031106. [DOI] [PubMed] [Google Scholar]
  30. Ogawa T., Takada H., Kotani S., Sato H., Sato Y. Novel biological property of pertussis toxin: chemotactic activity on human monocytes. Infect Immun. 1983 Jul;41(1):420–422. doi: 10.1128/iai.41.1.420-422.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Oropeza-Rendon R. L., Speth V., Hiller G., Weber K., Fischer H. Prostaglandin E1 reversibly induces morphological changes in macrophages and inhibits phagocytosis. Exp Cell Res. 1979 Mar 15;119(2):365–371. doi: 10.1016/0014-4827(79)90365-3. [DOI] [PubMed] [Google Scholar]
  32. Pick E. Cyclic AMP affects macrophage migration. Nat New Biol. 1972 Aug 9;238(84):176–177. doi: 10.1038/newbio238176a0. [DOI] [PubMed] [Google Scholar]
  33. Pittman M., Furman B. L., Wardlaw A. C. Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses. J Infect Dis. 1980 Jul;142(1):56–66. doi: 10.1093/infdis/142.1.56. [DOI] [PubMed] [Google Scholar]
  34. Pittman M. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev Infect Dis. 1979 May-Jun;1(3):401–412. doi: 10.1093/clinids/1.3.401. [DOI] [PubMed] [Google Scholar]
  35. Sato Y., Cowell J. L., Sato H., Burstyn D. G., Manclark C. R. Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun. 1983 Jul;41(1):313–320. doi: 10.1128/iai.41.1.313-320.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sato Y., Izumiya K., Sato H., Cowell J. L., Manclark C. R. Aerosol infection of mice with Bordetella pertussis. Infect Immun. 1980 Jul;29(1):261–266. doi: 10.1128/iai.29.1.261-266.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schiffmann E., Corcoran B. A., Wahl S. M. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A. 1975 Mar;72(3):1059–1062. doi: 10.1073/pnas.72.3.1059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sekura R. D., Fish F., Manclark C. R., Meade B., Zhang Y. L. Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem. 1983 Dec 10;258(23):14647–14651. [PubMed] [Google Scholar]
  39. Snyderman R., Pike M. C., Fischer D. G., Koren H. S. Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1. J Immunol. 1977 Dec;119(6):2060–2066. [PubMed] [Google Scholar]
  40. Stephens C. G., Snyderman R. Cyclic nucleotides regulate the morphologic alterations required for chemotaxis in monocytes. J Immunol. 1982 Mar;128(3):1192–1197. [PubMed] [Google Scholar]
  41. Till G., Lenhard V., Gemsa D. Chemotactic activity of lectins in vitro. Z Immunitatsforsch Immunobiol. 1978 Mar;154(2):173–185. [PubMed] [Google Scholar]
  42. Unanue E. R. The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. Adv Immunol. 1981;31:1–136. doi: 10.1016/s0065-2776(08)60919-0. [DOI] [PubMed] [Google Scholar]
  43. Utsumi S., Sonoda S., Imagawa T., Kanoh M. Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. I. Extraction and partial purification of phagocytosis- and chemotaxis-inhibitory activities. Biken J. 1978 Dec;21(4):121–135. [PubMed] [Google Scholar]
  44. Wardlaw A. C., Parton R. Bordetella pertussis toxins. Pharmacol Ther. 1982;19(1):1–53. doi: 10.1016/0163-7258(82)90041-9. [DOI] [PubMed] [Google Scholar]
  45. Wilkinson P. C. Leukocyte locomotion and chemotaxis: effects of bacteria and viruses. Rev Infect Dis. 1980 Mar-Apr;2(2):293–318. doi: 10.1093/clinids/2.2.293. [DOI] [PubMed] [Google Scholar]
  46. Wolff J., Cook G. H., Goldhammer A. R., Berkowitz S. A. Calmodulin activates prokaryotic adenylate cyclase. Proc Natl Acad Sci U S A. 1980 Jul;77(7):3841–3844. doi: 10.1073/pnas.77.7.3841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yajima M., Hosoda K., Kanbayashi Y., Nakamura T., Takahashi I., Ui M. Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis. J Biochem. 1978 Jan;83(1):305–312. doi: 10.1093/oxfordjournals.jbchem.a131905. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES